Combination Treatment for Severe Forms of Mucopolysaccharidosis, Type I (Hurler Syndrome): Case Report
Background. Hurler syndrome (mucopolysaccharidosis, type I) is a rare hereditary disease with chronic course. The main methods for Hurler syndrome management are hematopoietic stem cell transplantation (HSCT) and enzyme replacement therapy (ERT). In recent years, combination treatment (ERT administr...
Saved in:
Main Authors: | Nato V. Vashakmadze, Natalia V. Zhurkova, Marina A. Babaykina, Albina V. Dobrotok, Olga B. Gordeeva, Leyla S. Namazova-Baranova |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2023-12-01
|
Series: | Вопросы современной педиатрии |
Subjects: | |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/3361 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplantation Results in Patients with Hurler Syndrome: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2019-09-01) -
Mucopolysaccharidosis Type I (Hurler – Scheie Syndrome): Case Report
by: Nato D. Vashakmadze, et al.
Published: (2024-09-01) -
Orthopedic Pathology in Children with Mucopolysaccharidosis Type I
by: Nato D. Vashakmadze, et al.
Published: (2016-12-01) -
Differential Diagnosis of Hurler and Hurler–Scheie Syndromes: Clinical Case
by: Nataliya V. Buchinskaya, et al.
Published: (2025-05-01) -
Rare cases of mucopolysaccharidosis type I in children with Hurler and Hurler-Scheie syndromes
by: A. E. Babushkin, et al.
Published: (2018-10-01)